Drug Type Small molecule drug |
Synonyms- |
Target |
Mechanism NMUR2 agonists(neuromedin U receptor 2 agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC40H72N12O8 |
InChIKeyCNNVQJJHHRQWSW-HPMAGDRPSA-N |
CAS Registry2240202-02-0 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Obesity | Preclinical | JP | 01 May 2020 |